Ixazomib
CAS: 1072833-77-2
Ref. TM-T2122
| 1mg | 48.00 € | ||
| 5mg | 93.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 274.00 € | ||
| 50mg | 460.00 € | ||
| 100mg | 639.00 € | ||
| 500mg | 1,328.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
Product Information
Name:
Ixazomib
Synonyms:
- MLN2238
- MLN 2238
- B-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
- Ninlaro
- Boronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-
Description:
Ixazomib (MLN2238) is a boron-based peptide proteasome inhibitor targeting β5 site (IC50: 3.4 nM), also affecting β1 and β2 sites.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
361.03
Formula:
C14H19BCl2N2O4
Purity:
98% - 98.92%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T2122 Ixazomib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
